Record High: E-cigarette Use in the UK Up 10-fold in 10 Years

Aug.29.2022
Record High: E-cigarette Use in the UK Up 10-fold in 10 Years
A report shows e-cigarette usage has rapidly risen in the UK, with an estimated 4.3 million regular users.

A report has revealed that over the past decade, the use of electronic cigarettes has rapidly increased in the UK, reaching a record high with an estimated 4.3 million individuals regularly using e-cigarettes. Data suggests that 8.3% of adults in England, Wales, and Scotland are e-cigarette users, a significant increase from 1.7% ten years ago, which accounts for approximately 800,000 individuals using e-cigarettes. The report was conducted by Action on Smoking and Health (ASH), who suggest that over the past decade, there has been an 'e-cigarette revolution.'


Hazel Cheeseman, Deputy CEO of Ash, has stated that the increasing number of smokers switching to electronic cigarettes is "good news".


For those trying to quit smoking, they can be a lifesaving tool. However, relying solely on vaping to solve smoking addiction is not the answer. We must address the recent rise of young people vaping and implement broader efforts to combat smoking, as e-cigarettes are not suitable for everyone. It is time for the government to take action," she said.


According to a report, out of the 4.3 million e-cigarette users, approximately 2.4 million were previous smokers, 1.5 million were current smokers, and 350,000 had never smoked before. Cheeseman stated that e-cigarettes among the latter group are often "rare" and "experimental." The report showed that e-cigarettes have become particularly popular among young adults, with those aged 18 to 24 being the largest consumer group in 2022, accounting for 11%. This number has been growing since 2021 when their e-cigarette usage was at its lowest, at 5%. The rate among those aged 55 and above is the lowest, at 5.9%.


Cheeseman expressed concern, particularly in light of early research showing that the use of e-cigarettes among 11 to 17-year-olds has risen from 4% in 2020 to 7% in 2022, despite the fact that selling e-cigarettes to those under 18 is illegal. However, the research also indicates a decrease in smoking rates with the increase in e-cigarette use. The report is based on the annual Smokefree GB survey conducted by YouGov among over 13,000 adults from across the UK and found that 28% of current smokers have never tried e-cigarettes, 21% said they did not want to replace one addiction with another, 23% thought e-cigarette use was not similar enough to smoking, and 10% were "concerned about the safety of e-cigarettes”. A third of adults believed that e-cigarettes were either more harmful than smoking or equally harmful, which the report's authors say is incorrect.


In 2022, 35% of current e-cigarette users also smoke traditional cigarettes. Among this group, those who use e-cigarettes daily smoke fewer traditional cigarettes than those who use them infrequently.


Statement


This article is compiled from third-party information and is intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the content. The translation of this article is only intended for industry exchange and research.


Due to limited translation ability, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS fully aligns its statements and positions regarding domestic, Hong Kong, Macau, Taiwan, and foreign affairs with that of the Chinese government.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
UK consumer goods group Supreme said its vaping revenue rose 15% to £148.1 million in the year to March 31, 2026, despite the UK disposable vape ban taking effect during the period, while the company identified the Vaping Products Duty due in October as the next major industry milestone.
Regulations
Jul.03 by 2Firsts Perspectives
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
U.S. Appeals Court Says BAT Must Face Class Action Over Cigarette Labels
U.S. Appeals Court Says BAT Must Face Class Action Over Cigarette Labels
A U.S. appeals court ruled that British American Tobacco (BAT) must continue facing a consumer class action lawsuit over cigarette labels. The ruling allows the case to proceed but does not determine that BAT violated the law or is liable for damages. The case highlights ongoing legal risks facing major tobacco companies related to product labeling, consumer disclosures and product liability claims.
Jul.31
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Product | PMI Introduces VEEV inPrime, Bringing an Induction Vaporization Platform to the Next Generation of the VEEV Portfolio
Product | PMI Introduces VEEV inPrime, Bringing an Induction Vaporization Platform to the Next Generation of the VEEV Portfolio
Philip Morris International (PMI) has introduced VEEV inPrime, the next-generation closed-system vape platform featuring the new AdvanceVape Induction System™. Alongside the new induction platform, PMI has redesigned the pods, e-liquid formulations and user interaction experience. According to PMI and official IQOS websites, VEEV inPrime began a phased European rollout between May and June 2026, with products now available in Greece, Estonia, the United Kingdom and Italy.
Jul.14